Breaking News Instant updates and real-time market news.

TRVN

Trevena

$1.80

0.2 (12.50%)

, TTPH

Tetraphase

$6.47

0.17 (2.70%)

17:29
01/02/18
01/02
17:29
01/02/18
17:29

On The Fly: After Hours Movers

HIGHER: Trevena (TRVN), up 20% after it announced FDA acceptance for review of OLINVO... Tetraphase (TTPH), up 5.9% after it submitted an FDA application for eravacycline in cIAI treatment. LOWER: MoneyGram (MGI), down 5% after it terminated its merger agreement with Ant Financial... Howard Hughes (HHC), down 3.3% after it filed to sell 2.5M shares of common stock... Sempra Energy (SRE), down 2.3% after it filed to sell $2.5B in common stock and after it cited the recent U.S. tax legislation among its risk factors.

TRVN

Trevena

$1.80

0.2 (12.50%)

TTPH

Tetraphase

$6.47

0.17 (2.70%)

MGI

MoneyGram

$13.31

0.13 (0.99%)

HHC

Howard Hughes

$132.84

1.43 (1.09%)

SRE

Sempra Energy

$105.35

-1.8025 (-1.68%)

  • 02

    Jan

  • 23

    Jan

  • 24

    Jan

  • 05

    Jan

TRVN Trevena
$1.80

0.2 (12.50%)

10/16/17
LEHM
10/16/17
DOWNGRADE
Target $2.5
LEHM
Equal Weight
Trevena downgraded to Equal Weight from Overweight at Barclays
Barclays analyst Douglas Tsao downgraded Trevena to Equal Weight and cut his price target for the shares to $2.50 from $15. The analyst says the downgrade reflects uncertainty in the commercial outlook for Olinvo. He sees a financing overhang and limited catalysts for the shares.
10/13/17
OPCO
10/13/17
NO CHANGE
Target $5
OPCO
Outperform
Trevena selloff yesterday likely overdone, says Oppenheimer
Oppenheimer analyst Derek Archila views Trevena's restructuring plan as a "smart move" with the company needing to conserve cash for an Olinvo approval/launch in the second half of 2018. The analyst continues to believe Olinvo for post-surgical pain will find its "niche" as a treatment for patients at high risk of opioid related adverse events. He views yesterday's 15% pullback as likely overdone and keeps an Outperform rating on Trevena. The analyst, though, cut his price target for the shares to $5 from $8.
02/23/17
HCWC
02/23/17
NO CHANGE
Target $8
HCWC
Buy
Trevena price target lowered to $8 from $11 at H.C. Wainwright
H.C. Wainwright analyst Ed Arce lowered his price target for Trevena to $8 to reflect reduced expectations on Olinvo's commercial uptake following the Phase 3 readouts. The analyst does not believe commercial success is an "all-or-nothing" proposition, however, and keeps a Buy rating on the shares.
03/14/17
OPCO
03/14/17
NO CHANGE
Target $10
OPCO
Outperform
Trevena selloff overdone, says Oppenheimer
Oppenheimer analyst Derek Archila says that despite the company's mixed results relative to morphine, he believes the recent selloff is overdone and that Olinvo will be approved given its statistically significant results versus placebo. The analyst thinks Olinvo remains commercially viable given the trends on improved safety from the APOLLO studies, and should become an important option for patients most at risk for opioid-related adverse events. He reiterates an Outperform rating and $10 price target.
TTPH Tetraphase
$6.47

0.17 (2.70%)

10/05/17
BMOC
10/05/17
NO CHANGE
BMOC
Tetraphase price target raised to $24 from $13 at BMO Capital
BMO Capital analyst M. Ian Somaiya says Phase I data on the oral version of Tetraphase's eravacycline indicate that dose changes "and meal timing can effectively double drug exposure." The analyst says that the exposure levels of the oral treatment are now 80%-90% of the IV version. He raised his estimate of the oral version's chance of success to 33% from 25% and increased his price target on the shares to $24 from $13. He keeps an Outperform rating on the stock.
11/06/17
HCWC
11/06/17
NO CHANGE
Target $17
HCWC
Buy
Tetraphase price target raised to $17 from $15 at H.C. Wainwright
H.C. Wainwright analyst Ed Arce raised his price target for Tetraphase to $17 saying the six corporate milestones laid out in the Q3 earnings release "highlight several potential value-creating stock catalysts in 2018." The analyst believes the company is well positioned to achieve the milestones. He keeps a Buy rating on the shares.
10/18/17
PIPR
10/18/17
NO CHANGE
Target $14
PIPR
Overweight
Piper a buyer of Tetraphase after meeting with key opinion leader
After hosting a client lunch with Dr. Andrew Shorr from MedStar Washington Hospital Center and Georgetown University, Piper Jaffray analyst Edward Tenthoff say he remains a buyer of Tetraphase Pharmaceuticals. The doctor highlighted the need for new agents to treat ESBL-producing gram-negative infections in the hospital setting, Tenthoff tells investors in a research note. He sees a place for front-line use of Tetraphase's eravacycline as well as a destination therapy. The analyst recommends buying Tetraphase ahead of a "busy" Q1 of 2018 and reiterates an Overweight rating on the name with a $14 price target.
10/06/17
RHCO
10/06/17
NO CHANGE
Target $19
RHCO
Buy
Tetraphase oral eravacycline data 'encouraging,' says SunTrust
SunTrust analyst Edward Nash says the Phase I data on oral eravacycline to be presented by Tetraphase at tomorrow's IDWeek 2017 session "shows strong promise". Nash notes that optimized fasting period around the oral dosing regimen leads to improved performance of the treatment, suggesting the IGNITE2 failure may have been the result of suboptimal food effect. The analyst maintains a Buy rating on the stock with a $19 price target.
MGI MoneyGram
$13.31

0.13 (0.99%)

07/25/17
DADA
07/25/17
NO CHANGE
DADA
Euronet would benefit if Moneygram deal blocked, says DA Davidson
After media outlets reported that the U.S. government could block the acquisition of Moneygram (MGI) by Alibaba's (BABA) Ant Financial, DA Davidson analyst Peter Heckmann indicates that such a development would help Euronet (EEFT). He notes that Euronet previously made an unsuccessful bid for Moneygram. He believes that if Euronet is able to acquire Moneygram, the deal would be "transformational" and " would provide visibility to attractive revenue and earnings growth into 2020". Conversely, if Ant acquires Moneygram, Euronet and Western Union (WU) could come under increased pressure, the analyst stated. He keeps a Buy rating on Euronet. .
12/12/17
JPMS
12/12/17
DOWNGRADE
Target $13
JPMS
Underweight
MoneyGram downgraded to Underweight from Neutral at JPMorgan
JPMorgan analyst Tien-tsin Huang downgraded MoneyGram to Underweight and cut his price target for the shares to $13 from $18. It is more likely than not that the Ant Financial deal will be blocked by the Committee on Foreign Investment in the United States, Huang tells investors in a research note. He also believes weakness in trends year-to-date has likely hurt MoneyGram's standalone value.
03/14/17
BTIG
03/14/17
NO CHANGE
BTIG
BTIG says Western Union positive reaction to MoneyGram news makes sense
BTIG analyst Mark Palmer said he believes the uptick in Western Union (WU) shares after the announcement of Euronet's (EEFT) offer to buy competitor MoneyGram (MGI) makes some sense as Euronet may be seen as less of a competitive threat than Alibaba's (BABA) Ant Financial, which previously struck a deal to buy MoneyGram, and the bid underscores the attractiveness and potential of the global remittance space. However, speculation that if Ant was unsuccessful in its effort to acquire MoneyGram it could look to acquire VeriFone (PAY) or Green Dot (GDOT) "makes less sense," said Palmer.
03/14/17
RHCO
03/14/17
NO CHANGE
RHCO
Buy
SunTrust says buy Euronet on MoneyGram deal selloff
Euronet's (EEFT) $1.8B offer to acquire MoneyGram (MGI) is "superior in all ways" to Ant Financial's, which is owned by Alibaba (BABA), SunTrust analyst Andrew Jeffrey tells investors in a research note. He expects shares of Euronet to come under pressure this morning "as many investors simply do not like global remittance." Jeffrey recommends using the weakness to buy Euronet, however, as he feels the company has a differentiated franchise and superior management and growth strategy.
HHC Howard Hughes
$132.84

1.43 (1.09%)

03/30/17
SDLR
03/30/17
INITIATION
Target $123
SDLR
Hold
Howard Hughes initiated with a Hold at Sandler O'Neill
Sandler O'Neill analyst Alexander Goldfarb initiated Howard Hughes with a Hold and a $123 price target citing valuation and the late stage of the economic cycle.
06/08/17
BWSF
06/08/17
INITIATION
Target $150
BWSF
Buy
Howard Hughes initiated with a Buy at BWS Financial
BWS Financial analyst Hamed Khorsand initiated Howard Hughes with a Buy rating and $150 price target, saying he believes now is the time get involved with Houston starting to show signs of stability and its Seaport project becoming commercially ready.
06/08/17
BWSF
06/08/17
INITIATION
Target $150
BWSF
Buy
Howard Hughes initiated with a Buy at BWS Financial
BWS Financial analyst Vahid Khorsand started Howard Hughes with a Buy rating and $150 price target. With the Houston economy starting to show signs of stability, and Seaport commercially ready, now is the buy to buy the stock, the analyst tells investors in a research note.
SRE Sempra Energy
$105.35

-1.8025 (-1.68%)

12/22/17
BOFA
12/22/17
DOWNGRADE
Target $112
BOFA
Neutral
Sempra Energy downgraded to Neutral from Buy at BofA/Merrill
BofA/Merrill analyst Julien Dumoulin-Smith downgraded Sempra Energy to Neutral and cut its price target to $112 from $125 due to ongoing wildfire risk, which will be an overhang for the company. The analyst added the recent selloff in shares also puts pressure on the upcoming $6B equity raise and accretion metrics for Oncor.
06/08/17
LEHM
06/08/17
DOWNGRADE
Target $121
LEHM
Equal Weight
Sempra Energy downgraded to Equal Weight from Overweight at Barclays
Barclays analyst Daniel Ford downgraded Sempra Energy (SRE) to Equal Weight with the shares close to his unchanged price target of $121. The analyst is increasingly concerned that the Cameron LNG export facility could face construction delays given the project's association with CB&I (CBI).
10/11/17
GSCO
10/11/17
UPGRADE
Target $129
GSCO
Buy
Sempra Energy upgraded to Buy from Neutral at Goldman Sachs
Goldman Sachs analyst Michael Lapides upgraded Sempra Energy to Buy and raised his price target for the shares to $129 from $117. Utility and infrastructure project developments in the U.S. and Mexico create an "active catalyst path" over the next six-to-nine months, Lapides tells investors in a research note. Further, the analyst believes the proposed acquisition of Energy Future Holdings could drive higher growth.

TODAY'S FREE FLY STORIES

10:01
05/22/18
05/22
10:01
05/22/18
10:01
General news
Richmond Fed Manufacturing Index Level data reported »

May Richmond Fed…

BMRN

BioMarin

$85.09

-4.26 (-4.77%)

10:00
05/22/18
05/22
10:00
05/22/18
10:00
Periodicals
STAT's Feuerstein says 'didn't pick up significant red flags' in BioMarin slides »

Adam Feuerstein of STAT…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 25

    May

  • 12

    Sep

MU

Micron

$59.85

4.37 (7.88%)

, AZO

AutoZone

$696.72

31.04 (4.66%)

09:55
05/22/18
05/22
09:55
05/22/18
09:55
Options
Early notable gainers among liquid option names on May 22nd »

Notable gainers among…

MU

Micron

$59.85

4.37 (7.88%)

AZO

AutoZone

$696.72

31.04 (4.66%)

LRCX

Lam Research

$203.57

3.65 (1.83%)

FITB

Fifth Third

$31.41

0.52 (1.68%)

ADBE

Adobe

$241.86

3.86 (1.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 22

    May

  • 30

    May

  • 07

    Jun

09:55
05/22/18
05/22
09:55
05/22/18
09:55
Conference/Events
House Energy & Commerce Committee to hold a hearing »

The Energy Subcommittee…

WBA

Walgreens Boots Alliance

$65.27

0.77 (1.19%)

09:55
05/22/18
05/22
09:55
05/22/18
09:55
Conference/Events
Walgreens Boots Alliance to hold sell-side analyst event »

Sell-Side Analyst Event…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

09:55
05/22/18
05/22
09:55
05/22/18
09:55
Conference/Events
House Transportation & Infrastructure Committee to hold a hearing »

The Subcommittee on…

AHL

Aspen Insurance

$43.50

(0.00%)

, HIG

Hartford Financial

$53.31

-0.3 (-0.56%)

09:54
05/22/18
05/22
09:54
05/22/18
09:54
Periodicals
Hartford among suitors still pursuing Aspen Insurance, Re-Insurance says »

Hartford (HIG) is through…

AHL

Aspen Insurance

$43.50

(0.00%)

HIG

Hartford Financial

$53.31

-0.3 (-0.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMRN

BioMarin

$86.01

-3.34 (-3.74%)

, ONCE

Spark Therapeutics

$75.45

2.42 (3.31%)

09:52
05/22/18
05/22
09:52
05/22/18
09:52
Recommendations
BioMarin, Spark Therapeutics analyst commentary  »

BioMarin shares…

BMRN

BioMarin

$86.01

-3.34 (-3.74%)

ONCE

Spark Therapeutics

$75.45

2.42 (3.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 25

    May

  • 10

    Sep

  • 12

    Sep

LOW

Lowe's

$89.86

2.49 (2.85%)

, JCP

J.C. Penney

$2.33

-0.175 (-6.99%)

09:50
05/22/18
05/22
09:50
05/22/18
09:50
Recommendations
Lowe's, J.C. Penney, Home Depot analyst commentary  »

Baird calls new…

LOW

Lowe's

$89.86

2.49 (2.85%)

JCP

J.C. Penney

$2.33

-0.175 (-6.99%)

HD

Home Depot

$190.38

0.63 (0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 23

    May

  • 30

    May

09:50
05/22/18
05/22
09:50
05/22/18
09:50
Hot Stocks
Breaking Hot Stocks news story  »

Rosehill Resources Inc…

UBNK

United Financial

$17.99

(0.00%)

09:48
05/22/18
05/22
09:48
05/22/18
09:48
Hot Stocks
United Financial announces purchase of six bank branches »

United Bank of Hartford,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$274.00

0.74 (0.27%)

09:46
05/22/18
05/22
09:46
05/22/18
09:46
Technical Analysis
Technical Take: SPDR S&P 500 ETF edges higher after first 15 minutes »

At time of writing the…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$274.00

0.74 (0.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMRN

BioMarin

$84.77

-4.58 (-5.13%)

09:45
05/22/18
05/22
09:45
05/22/18
09:45
Recommendations
BioMarin analyst commentary  »

BioMarin shares defended…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 25

    May

  • 12

    Sep

09:45
05/22/18
05/22
09:45
05/22/18
09:45
Hot Stocks
Breaking Hot Stocks news story  »

Rosehill Resources Inc…

KSS

Kohl's

$64.91

-0.56 (-0.86%)

09:45
05/22/18
05/22
09:45
05/22/18
09:45
Hot Stocks
Breaking Hot Stocks news story on Kohl's »

Kohl's 'feels…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

09:45
05/22/18
05/22
09:45
05/22/18
09:45
General news
Richmond Fed Manufacturing Index Level to be reported at 10:00 »

May Richmond Fed…

PSTG

Pure Storage

$23.60

(0.00%)

09:44
05/22/18
05/22
09:44
05/22/18
09:44
Recommendations
Pure Storage analyst commentary  »

Pure Storage price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 07

    Jun

  • 12

    Jun

  • 10

    Jul

DF

Dean Foods

$9.79

(0.00%)

09:40
05/22/18
05/22
09:40
05/22/18
09:40
Periodicals
Dean Foods seen as target, but may struggle to find buyer, Dealreporter says »

Dean Foods is viewed as a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FOX

21st Century Fox

$37.45

(0.00%)

, FOXA

21st Century Fox

$37.92

(0.00%)

09:38
05/22/18
05/22
09:38
05/22/18
09:38
Periodicals
Fox shareholder vote date should be announced in 'week or two,' CNBC reports »

21st Century Fox (FOXA)…

FOX

21st Century Fox

$37.45

(0.00%)

FOXA

21st Century Fox

$37.92

(0.00%)

DIS

Disney

$104.05

(0.00%)

CMCSA

Comcast

$32.34

(0.00%)

CMCSK

Comcast

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:36
05/22/18
05/22
09:36
05/22/18
09:36
Hot Stocks
Breaking Hot Stocks news story  »

Liberty TripAdvisor…

09:32
05/22/18
05/22
09:32
05/22/18
09:32
Conference/Events
House Committee on Foreign Affairs to hold a hearing »

The Terrorism,…

RLH

Red Lion Hotels

$10.45

(0.00%)

09:32
05/22/18
05/22
09:32
05/22/18
09:32
Hot Stocks
Red Lion Hotels announces long-term consulting agreement with key executives »

RLH announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 29

    May

BOSC

B.O.S. Better Online

$2.26

(0.00%)

09:31
05/22/18
05/22
09:31
05/22/18
09:31
Hot Stocks
B.O.S. Better Online supply chain division receives $150,000 order »

B.O.S. Better Online…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

09:31
05/22/18
05/22
09:31
05/22/18
09:31
Hot Stocks
Breaking Hot Stocks news story  »

Liberty TripAdvisor…

EXR

Extra Space Storage

$92.96

(0.00%)

09:30
05/22/18
05/22
09:30
05/22/18
09:30
Recommendations
Extra Space Storage analyst commentary  »

Extra Space Storage price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.